Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: Insulin-like growth factor I and procollagen type III peptide

International Journal of Sports Medicine

Volumn 27, Issue 12, 2006, Pages 976-983

  Abellan, R ^a,b   Ventura, R ^a,b   Pichini, S ^c   Di Giovannandrea, R ^c   Bellver, M ^d   Olive, R ^d   Pacifici, R ^c   Pascual, J A ^a,b   Zuccaro, P ^c   Segura, Jordi ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Centre d'Alt Rendiment   (Spain)

Author keywords

Athletes; GH doping detection; IGF I; P III P; Training

Indexed keywords

BIOLOGICAL MARKER; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ANTHROPOMETRY; ARTICLE; ATHLETE; CONTROLLED STUDY; ENDURANCE; FEMALE; FITNESS; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CHILD; COLLAGEN TYPE III; DOPING IN SPORTS; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDE FRAGMENTS; PHYSICAL ENDURANCE; PHYSICAL FITNESS; REFERENCE VALUES;

EID: 33845388841     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-923864     Document Type: Article

References (39)

1. Abellan R, Ventura R, Pichini S, Pascual JA, Pacific R, Di Carlo S, Bacosi A, Segura J, Zuccaro P. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport. Clin Chem Lab Med 2005; 43: 75-85
2. Borst SE, De Hoyos DV, Garzarella L, Vincent K, Pollock BH, Lowenthal DT, Pollock ML. Effects of resistance training on insulin-like factor-I and IGF binding proteins. Med Sci Sports Exerc 2001; 33: 648-653
3. Cappon J, Brasel JA, Mohan S, Cooper DM. Effect of brief exercise on circulating insulin-like growth factor J Appl Physiol 1994; 76: 2490-2496
4. Dall R, Lange KHW, Kjaer M, Jorgensen JOL, Christiansen JS, Orskov H, Flyvbjerg A. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 2001; 86: 669-674
5. De Palo EF, Gatti R, Lancerin F, Cappelin E, Spinella P. Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes. Clin Chim Acta 2001; 305: 1-17
6. Ehrnborg C, Lange KHW, Dall R, Christiansen JS, Lundberg P-A, Baxter RC, Boroujerdi MA, Bengtsson B-A, Healy M-L, Pentecost C, Longobardi S, Napoli R, Rosen T. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 2003; 88: 394-401
7. Fleischmajer R, Perlish JS, Burgeson RE, Shaikh-Bahai F, Timpl R. Type I and type III collagen interactions during fibrillogenesis. Ann NY Acad Sci 1990; 580: 161-175
8. Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 1999; 39: E1009-E1013
9. Healy M-L, Dall R, Gibney J, Basset E, Ehrnborg C, Pentecost C, Rosen T, Cittadini A, Baxter RC, Sonksen PH. Towards the development of a test for growth hormone abuse. Study of extreme physiological ranges of growth hormone dependent markers in 813 elite athletes in the post-competition setting. J Clin Endocrinol Metab 2005; 90: 641-649
10. Jahreis G, Hesse V, Schmidt HE, Scheibe J. Effect of endurance exercise on somatomedin-C/insulin-like growth factor I concentration in male and female runners. Exp Clin Endocrinol 1989; 94: 89-96
11. Jenkins PJ. Growth hormone and exercise: physiology, use and abuse. GH IGF Res 2001; Suppl A, S71-S77
12. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE. Serum insulin-like growth factor in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752
13. Kargotich S, Goodman C, Keast D, Morton D. The influence of exercise-induced plasma volume changes on the interpretation of biochemical parameters used for monitoring exercise, training and sport. Sports Med 1998; 26: 101-117
14. Kicman AT, Miell JP, Teale JD, Powrie J, Wood PJ, Laidler P, Milligan PJ, Cowan DA. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH. Clin Endocrinol 1997; 47: 43-50
15. Koistinen H, Koistinen R, Selenius L, Ylikorkala O, Seppala M. Effect of marathon run on serum IGF-I and IGF-bindings protein 1 and 3 levels. J Appl Physiol 1996; 80: 760-764
16. Koziris LP, Hickson RC, Chatterton RT, Groseth RT, Christie JM, Goldflies DG, Unterman TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 1999; 86: 1436-1442
17. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosen T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jorgensen JO, Sacca L. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 2000; 85: 1505-1512
18. Marx JO, Ratamess NA, Nindl BC, Gotshalk LA, Volek JS, Dohi K, Bush JA, Gomez AL, Mazzetti SA, Fleck SJ, Hakkinen K, Newton RU, Kraemer J. Low-volume circuit versus high-volume periodized resistance training in women. Med Sci Sports Exerc 2001; 33: 635-643
19. Nguyen UN, Mougin F, Simon-Rigaud ML, Rouillon JD, Marguet P, Regnard J. Influence of exercise duration on serum insulin-like growth factor and its binding proteins. Eur J Appl Physiol 1998; 78: 533-537
20. Nindl BC, Kraemer WJ, Marx JO, Arciero PJ, Dohi K, Kellogg MD, Loomis GA. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol 2001; 90: 1319-1326
21. Nindl BC, Castellani JW, Young AJ, Patton JF, Khosravi MJ, Diamandi A, Montain SJ. Differential responses of IGF-I molecular complexes to military operational field training. J Appl Physiol 2003; 95: 1083-1089
22. Quarmby V, Quan C, Ling V, Compton P, Canova-Davis E. How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy. J Clin Endocrinol Metab 1998; 83: 1211-1216
23. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715-718
24. Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Orskov H, Kjaer M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol 2002; 93: 1669-1675
25. Saggese G, Baroncelli GI, Bertollini S, Cinquanta L, DiNero G. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr Res 1994; 35: 409-415
26. Sartorio A, Agosti F, Marazzi N, Maffiuletti NA, Cella SG, Rigamonti AE, Guidetti L, Di Luigi L, Muller EE. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report. Clin Endocrinol 2004; 61: 487-493
27. Sartorio A, Marazzi N, Agosti F, Faglia G, Corradini C, De Palo E, Cella SG, Rigamonti AE, Muller EE. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: A study on-the-field. J Endocrinol Invest 2004; 27: 410-415
28. Schumacher YO, Jankovits R, Bültermann D, Schmidt A, Berg A. Hematological indices in elite cyclists. Scand J Med Sci Sports 2002; 12: 301-308
29. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996; 81: 3492-3497
30. Skjaerbaek C, Frystyk J, Kaal A, Laursen T, Moller J, Weeke J, Jorgensen JOL, Christiansen JS, Orskov H. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency. Clin Endocrinol 2000; 52: 25-33
31. Snow CM, Rosen CJ, Robinson TL Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass. Med Sci Sports Exerc 2000; 32: 1902-1907
32. Strasburger CJ, Bidlingmaier M, Wu Z, Morrison KM. Normal values of insulin-like growth factor I and their clinical utility in adults. Horm Res 2001; 55: 100-105
33. Suikkari A-M, Sane T, Seppala M, Yki-Jarvinen H, Karonen S-L, Koivisto VA. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J Clin Endocrinol Metab 1989; 68: 141-144
34. Takala TES, Vuori J, Anttinen H, Väänänen K, Myllyla R. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in concentration of type III procollagen aminopropeptide in human serum. Pflugers Arch 1986; 407: 500-503
35. Takala TES, Vuori JJ, Rahkila PJ, Hakala EO, Karpakka JA, Alen MJ, Orava YS, Väänänen HK. Carbonic anhydrase III and collagen markers in serum following cross-country skiing. Med Sci Sports Exerc 1989; 21: 593-597
36. Virtanen P, Viitasalo JT, Vuori J, Väänänen K, Takala TES. Effect of concentric exercise on serum muscle and collagen markers. J Appl Physiol 1993; 75: 1272-1277
37. Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, Dall R, Rosen T, Jorgensen JO, Cittadini A, Longobardi S, Sacca L, Christiansen JS, Bengtsson BA, Sonksen PH. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 1999; 84: 3591-3601
38. Wallace JD, Cuneo RC, Lundberg PA, Rosen T, Jorgensen JO, Longobardi S, Keay N, Sacca L, Christiansen JS, Bengtsson BA, Sonksen PH. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000; 85: 124-133
39. Zofkova I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res 2003; 52: 657-679